Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers

Practical Radiation Oncology

Volumn 4, Issue 6, 2014, Pages 384-391

  Liu, Wei ^a   Mohan, Radhe ^b   Park, Peter ^c   Liu, Zhong ^d   Li, Heng ^b   Li, Xiaoqiang ^b   Li, Yupeng ^e   Wu, Richard ^b   Sahoo, Narayan ^b   Dong, Lei ^f   Zhu, X Ronald ^b   Grosshans, David R ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SOUTHWESTERN UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^e VARIAN MEDICAL SYSTEMS   (United States)

^f Scripps Proton Therapy Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; AREA UNDER THE CURVE; ARTICLE; BRAIN REGION; CHONDROSARCOMA; CHORDOMA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COCHLEA; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RETROSPECTIVE STUDY; SKULL CANCER; TEMPORAL LOBE; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR VOLUME; COMPUTER ASSISTED RADIOTHERAPY; PROCEDURES; PROTON THERAPY; RADIOMETRY; SKULL BASE NEOPLASMS;

ALGORITHMS; CHONDROSARCOMA; CHORDOMA; HUMANS; PROTON THERAPY; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SKULL BASE NEOPLASMS;

EID: 84912521606     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2013.12.001     Document Type: Article

References (26)

1. Debus J., Hug E.B., Liebsch N.J., et al. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys 1997, 39:967-975.
2. Hug E.B., Loredo L.N., Slater J.D., et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999, 91:432-439.
3. Noël G., Feuvret L., Ferrand R., Boisserie G., Mazeron J.J., Habrand J.L. Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas. Neurosurgery 2004, 55:1252-1262.
4. Terahara A., Niemierko A., Goitein M., et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999, 45:351-358.
5. Lomax A.J. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties. Phys Med Biol 2008, 53:1027-1042.
6. Lomax A.J. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008, 53:1043-1056.
7. Liu W., Li Y., Li X., et al. Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques. Med Phys 2012, 39:3089-4001.
8. Liu W., Zhang X., Li Y., et al. Robust optimization in intensity-modulated proton therapy. Med Phys 2012, 39:1079-1091.
9. Park P.C., Zhu X.R., Lee A.K., et al. A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. Int J Radiat Oncol Biol Phys 2012, 82:e329-e336.
10. Albertini F., Hug E.B., Lomax A.J. Is it necessary to plan with safety margins for actively scanned proton therapy?. Phys Med Biol 2011, 56:4399-4413.
11. Chen W., Unkelbach J., Trofimov A., et al. Including robustness in multi-criteria optimization for intensity-modulated proton therapy. Phys Med Biol 2012, 57:591-608.
12. Fredriksson A. A characterization of robust radiation therapy treatment planning methods-from expected value to worst case optimization. Med Phys 2012, 39:5169-5181.
13. Fredriksson A., Forsgren A., Hårdemark B. Minimax optimization for handling range and setup uncertainties in proton therapy. Med Phys 2011, 38:1672-1684.
14. Pflugfelder D., Wilkens J.J., Oelfke U. Worst case optimization: A method to account for uncertainties in the optimization of intensity modulated proton therapy. Phys Med Biol 2008, 53:1689-1700.
15. Stuschke M., Kaiser A., Pöttgen C., Lübcke W., Farr J. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. Radiother Oncol 2012, 104:45-51.
16. Unkelbach J., Bortfeld T., Martin B.C., Soukup M. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys 2009, 36:149-163.
17. Unkelbach J., Chan T.C.Y., Bortfeld T. Accounting for range uncertainties in the optimization of intensity modulated proton therapy. Phys Med Biol 2007, 52:2755-2773.
18. Lomax A.J., Boehringer T., Coray A., et al. Intensity modulated proton therapy: A clinical example. Med Phys 2001, 28:317-324.
19. Liu W., Frank S.J., Li X., et al. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys 2013, 40:051711.
20. Liu W., Frank S.J., Li X., Li Y., Zhu R.X., Mohan R. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization. Med Phys 2013, 40:021709.
21. Li Y., Zhu R.X., Sahoo N., Anand A., Zhang X. Beyond the two Gaussians: A study of single spot modeling for scanning proton dose calculation. Phys Med Biol 2012, 57:983-997.
22. Yang M., Zhu X.R., Park P.C., et al. Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol 2012, 57:4095-4115.
23. Moyers M.F., Sardesai M., Sun S., Miller D.W. Ion stopping powers and CT numbers. Med Dosim 2010, 35:179-194.
24. Lomax A.J., Pedroni E., Rutz H., Goitein G. The clinical potential of intensity modulated proton therapy. Z Med Phys 2004, 14:147-152.
25. Schwarz M. Treatment planning in proton therapy. Eur Phys J Plus 2011, 126:67-76.
26. Meyer J., Bluett J., Amos R., et al. Spot scanning proton beam therapy for prostate cancer: treatment planning technique and analysis of consequence of rotational and translational alignment errors. Int J Radiat Oncol Biol Phys 2010, 78:428-434.